Innovation and the Pharmaceutical Industry: Critical Reflections on the Virtues of Profit
Innovation and the Pharmaceutical Industry: Critical Reflections on the Virtues of Profit examines the central role of profit in the development of pharmaceuticals, medical devices, and health care generally. Recent efforts to understand this role have often underestimated and even dismissed its importance, arguing for its replacement by other means and mechanisms. However, as the essays in this volume attest, it would be impossible to account adequately for the range of pharmaceuticals and medical devices that have become part of everyday medicine without recognizing that the depth and scope of innovations are tied not simply to altruism, a concern for the common good, or the pursuit of knowledge for its own sake, but crucially to the pursuit of private good and of individual profit.
Balancing a concern for theory and practice, the analyses and evaluations provided in these essays touch directly on many of the most heated and important debates in pharmaceutical ethics, such as profit margins, corporate social responsibility, drug advertising, litigation, patents, and parallel trade. Reflecting critically on the problems and prospects of medical innovation, they invite a rethinking of the foundations of the bioethics and business ethics of the pharmaceutical and medical device industries by focusing on the long-term impact of policy decisions for human health and well-being.
What people are saying - Write a review
We haven't found any reviews in the usual places.
Other editions - View all
American argue argument Bendectin benefits Bioethics breast implants Business Ethics Canada choice Compliance Leveraging concern constraining option consumer corporate obligation costs decisions doctors drug companies economic employees Epstein funds Goodman Graber and Tansey harm healthcare HSAs human ILTIS increase individuals informed consent intellectual property intuition investment issues jurors jury limited litigation maceutical manufacturers MARKET FOR DRUGS McDonald’s Medicaid medical devices medical-device industries Medicare ment moral name-brand pharmaceuticals National Online parallel importing parallel trade patient autonomy persons phar pharma pharmaceutical advertising pharmaceutical and medical-device pharmaceutical companies pharmaceutical industry pharmaceuticals and medical physicians plaintiffs prescription drugs price discrimination products liability proponents of SRT public policy pursuit of profit reason regulation regulatory Relman and Angell requires SANDRA H save lives scientific evidence social responsibility SRT accounts stakeholder theory third-party tion treatment TRISTRAM ENGELHARDT Xigris